Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

067080.KQ

STRONG SELL

DAE HWA Pharmaceutical Co., Ltd. · Healthcare · South Korea · $127M · Avg Vol: $807K/d

7
StockRank
Q
41
V
29
M
17
P/E (TTM)
112.9x
ROE
3.0%
D/E
1.2x
Dividend %
1.4%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue87M93M98M94M2.7%
EPS0.04-0.040.020.0613.7%
Shares19M19M19M18M-5.9%
Debt59M73M65M64M2.4%
Equity51M48M47M49M-1.7%
Op CF5M-141,1353M4M-12.8%
Inv CF-17M-10M3M-3M—
Fin CF11M11M-9M-660,910—
Loading...
PRICE (1M)-27.1%
6.837.758.679.5910.51May 6May 28Jun 18
SMA 50SMA 200
Close
$6.89
RSI (14)
27.2
52W High
$16.30
From 52W High
0.4%

SCORE BREAKDOWN

Quality
41
ROIC
10.7%75.2
ROE
3.0%50.8
GP/Assets
22.6%51.6
Op. Margin
1.2%46.8
FCF/Assets
-0.7%48.0
Piotroski
—28.7
Int. Cover
2.0x45.5
D/E Ratio
1.19x11.9
Current Ratio
0.53x2.4
Value
29
P/E (TTM)
112.9x8.1
EV/EBITDA
34.4x10.1
P/FCF
—N/A
P/B
2.5x46.2
P/S
1.3x78.2
Div Yield
1.4%38.9
Momentum
17
52W High %
42%14.9
RS 6M
-168%1.1
SMA 50/200
0.88x27.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$127M
P/E (Forward)
—
Gross Margin
33.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 067080.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
067080.KQDAE HWA Pharmaceutical Co., Ltd.(you)$127M7STRONG SELL
003520.KSYungjin Pharm. Co., Ltd.$158M10STRONG SELL
293780.KQAptaBio Therapeutics Inc.$91M3STRONG SELL
058820.KQCMG Pharmaceutical Co., Ltd.$107M14STRONG SELL
000520.KSSamil Pharmaceutical Co.,Ltd$105M14STRONG SELL
220100.KQFutureChem Co.,Ltd$222M6STRONG SELL
256840.KQBNC KOREA, Inc.$131M19STRONG SELL
092040.KQAmicogen, Inc.$58M7STRONG SELL
004310.KSHyundai Pharmaceutical Co., Ltd.$117M23SELL
032300.KQKOREA PHARMA Co., Ltd.$63M12STRONG SELL

Peer medians: ROE -1.3% · P/E 17.6x · Gross margin 43.6%

DAE HWA Pharmaceutical Co., Ltd. (067080.KQ) — Stock Score Summary

DAE HWA Pharmaceutical Co., Ltd. (067080.KQ) has a MoatMap StockRank of 7/100 based on Quality (41/100), Value (29/100), and Momentum (17/100) factor scores. The current signal is STRONG SELL.

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea.

Key Financial Metrics

Price$6.89
Market Cap$127M
P/E (TTM)112.87
Price/Book2.51
Return on Equity3.0%
Return on Invested Capital10.7%
Debt/Equity119.07
Gross Margin33.2%
Operating Margin1.2%
Revenue Growth1.0%
Dividend Yield1.4%
Free Cash Flow$-677.96

DAE HWA Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is DAE HWA Pharmaceutical Co., Ltd.’s (067080.KQ) StockRank?
MoatMap’s StockRank for DAE HWA Pharmaceutical Co., Ltd. (067080.KQ) is 7/100, with a Strong Sell signal. It is a composite of Quality (41), Value (29), and Momentum (17) factor ranks across MoatMap’s 20,000+ stock universe.
Does DAE HWA Pharmaceutical Co., Ltd. have an economic moat?
DAE HWA Pharmaceutical Co., Ltd. (067080.KQ) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is DAE HWA Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for DAE HWA Pharmaceutical Co., Ltd. (067080.KQ) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is DAE HWA Pharmaceutical Co., Ltd. in?
DAE HWA Pharmaceutical Co., Ltd. (067080.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks067080.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock